Leukos Biotech

LEUKOS BIOTECH LOGO

Contact information

Leukos Biotech
Enrique Llaudet
Muntaner 383, 3-2
Barcelona
Barcelona
931998148
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biomarkers
      • In vitro diagnostics
    • Therapeutic areas
      • Oncology
      • Blood and lymphatic system
Commissions

Leukos Biotech is a spin-off company form the Josep Carreras Leukaemia Research Institute.

We focus on developing new treatments and diagnostic tools for Leukaemia. We have identified a new therapeutic target against Leukemic Stem Cells in AML which will be validated, using a repurposed small molecule, in a Phase II clinical trial starting at the end of 2017.

The study will also cover the diagnosis and prognosis of AML patients according to the expression of this biomarker in blood.

Biotech Sanitaria

Drugs National Companies
Product / Service Type Therapeutic area Development phase
LB208 Biodrugs/ Drugs Oncología Preclinical